evoke study semaglutide When GLP-1s become brain drugs semaglutide evoke Medscape | Topline

Semaglutide is a GLP-1 receptor agonist, mimicking the natural hormone GLP-1 that regulates blood sugar

Patients report reduced cravings and smaller portion sizes, making it easier to stick to a healthier lifestyle

Patients initiating semaglutide therapy should undergo baseline blood pressure assessment as part of comprehensive cardiovascular risk evaluation

Conditions such as insulin resistance, polycystic ovary syndrome (PCOS), hypothyroidism, or untreated endocrine disorders may influence the appetite-suppressing effects of Ozempic

Klaritys licensed providers can evaluate whether semaglutide, tirzepatide, or other weight loss medications may be right for you fully online, same-day appointments with 2,000+ providers

Understanding that each patients journey to weight loss is unique, we offer a comprehensive range of solutions tailored to suit individual needs and lifestyles